Fig. 1From: Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisisComplement activation markers in systemic sclerosis and other autoimmune diseases. Graphs show mean and standard deviation of C4d (left panel), C3bBbP (middle panel) and soluble terminal complement complex (TCC) (right panel) concentrations. Value obtained for each patient (depicted with single points) is an average of two independent experiments. Statistical analysis was performed by Kruskal-Wallis test with Dunn’s multiple comparisons post-test, and statistical significance was set at *p < 0.05 and ***p < 0.001.Abbreviation: CAU Complement activation unitsBack to article page